Cargando…
Cancer Immunotherapy with CAR T Cells: Well-trodden Paths and Journey Along Lesser-known Routes
BACKGROUND: Chimeric antigen receptor (CAR) T cell therapy is a clinically approved cancer immunotherapy approach using genetically engineered T cells. The success of CAR T cells has been met with challenges regarding efficacy and safety. Although a broad spectrum of CAR T cell variants and applicat...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sciendo
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784369/ https://www.ncbi.nlm.nih.gov/pubmed/36503716 http://dx.doi.org/10.2478/raon-2022-0049 |